trimethoprim has been researched along with 1-propan-2-yl-5-benzotriazolecarboxylic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bastien, D; Ebert, MC; Forge, D; Huang, TL; Kadnikova, N; Mayence, A; Pelletier, JN; Perron, F; Toulouse, J; Vanden Eynde, JJ | 1 |
1 other study(ies) available for trimethoprim and 1-propan-2-yl-5-benzotriazolecarboxylic acid
Article | Year |
---|---|
Fragment-based design of symmetrical bis-benzimidazoles as selective inhibitors of the trimethoprim-resistant, type II R67 dihydrofolate reductase.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Benzimidazoles; Catalytic Domain; Cell Line; Cell Proliferation; Drug Design; Drug Resistance, Bacterial; Enzyme Assays; Fibroblasts; Folic Acid Antagonists; Humans; Kinetics; Mice; Models, Molecular; Protein Binding; Recombinant Proteins; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Trimethoprim | 2012 |